Hyperuricemia With or Without Gout

3

Review clinical trials related to Hyperuricemia With or Without Gout. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Tart Cherry Citrate Effervescent Tablet for Urate-Lowering Therapy in Participants With Asymptomatic Hyperuricemia

The goal of this clinical trial is to learn whether tart cherry citrate effervescent tablets can lower uric acid levels in people with asymptomatic hyperuricemia (high uric acid levels without gout symptoms). The main question it aims to answer is: Does taking tart cherry citrate effervescent tablets lower uric acid levels more effectively than taking a placebo (inactive) tablet, when both groups also receive lifestyle guidance? Researchers will compare two groups of participants. Both groups will receive lifestyle guidance (advice on diet and exercise). In addition: * One group will take the tart cherry citrate effervescent tablets. * The other group will take a placebo effervescent tablet (looks and tastes the same but contains no active ingredient). The study will last 24 weeks. Participants will: * Take the assigned effervescent tablet twice daily for 24 weeks * Follow lifestyle guidance for diet and exercise * Attend scheduled clinic visits for checkups and tests * Provide blood and urine samples for testing

Participants needed: 196
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Beijing Zhecheng Biotechnology Co., Ltd.Updated: Jun 17, 2026Locations: 1
Eligibility criteria

Aged 18 to 65 years, regardless of sex; [+3]

Known allergy to any of the study medications, food products, or their component... [+16]

Status: Not yet recruiting

Safety and Food Effect on Single-Dose Bioavailability of F-02-2-Na in Healthy Adult Subjects

The study is to evaluate the impact of food on the pharmacokinetics of F-02-2-Na in healthy adult subjects by observing the changes in the drug's pharmacokinetic profile-particularly in its absorption process-before and after food intake.

Participants needed: 12
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd.Updated: Jun 17, 2026Locations: 1
Eligibility criteria

1. The subjects should fully understand the purpose, nature, process of the stud... [+6]

1. Subjects with a specific allergic history (such as asthma, urticaria, eczema,... [+25]

Status: Recruiting

The Effects of a Probiotic Food Supplement in Hyperuricaemia

The overall aim of the project is to determine whether a daily intake of health-promoting bacteria, known as probiotics, with or without a dietary fiber, affects uric acid levels in individuals with elevated levels of uric acid in the blood (hyperuricemia). Additionally, the project will investigate which individuals benefit from this dietary supplement and which do not, based on factors such as gut microbiota composition and function, dietary habits, genetic factors, and inflammatory status. The ultimate goal is to develop a personalized therapy for hyperuricemia. At the beginning of the study, blood samples will be taken to determine uric acid levels and 99 individuals with hyperuricemia will be invited to participate in a 6-week intervention study with daily intake of dietary supplements. To examine the effect of the supplement on various health variables, blood, urine, stool, and breath samples will be collected on several occasions. To better understand the underlying factors of hyperuricemia, questionnaire data and results from biological will be compared between participants with normal versus elevated uric acid levels. Furthermore, different outcome parameters from questionnaires and samples before and after supplement intake will be compared. In addition, various methods for estimating dietary intake will be investigated and compared with each other.

Participants needed: 99
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Örebro University, SwedenUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

Signed informed consent prior to any study-related procedures [+5]

Recent (within last month) episode of gout [+13]